These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 20425045)
1. Prognostic value of WT1 protein expression level and MIB-1 staining index as predictor of response to WT1 immunotherapy in glioblastoma patients. Chiba Y; Hashimoto N; Tsuboi A; Rabo C; Oka Y; Kinoshita M; Kagawa N; Oji Y; Sugiyama H; Yoshimine T Brain Tumor Pathol; 2010 Apr; 27(1):29-34. PubMed ID: 20425045 [TBL] [Abstract][Full Text] [Related]
2. Implications of prognostic markers in brain tumors. Grzybicki DM; Moore SA Clin Lab Med; 1999 Dec; 19(4):833-47. PubMed ID: 10572718 [TBL] [Abstract][Full Text] [Related]
3. [Immunotherapy targeting the Wilms' tumor 1 gene product for patients with malignant brain tumors]. Hashimoto N; Tsuboi A; Chiba Y; Izumoto S; Oka Y; Yoshimine T; Sugiyama H Brain Nerve; 2009 Jul; 61(7):805-14. PubMed ID: 19618858 [TBL] [Abstract][Full Text] [Related]
4. Correlation of MIB-1 staining index and (201)Tl-SPECT retention index in preoperative evaluation of malignancy of brain tumors. Asano K; Takeda T; Nakano T; Ohkuma H Brain Tumor Pathol; 2010 Apr; 27(1):1-6. PubMed ID: 20425041 [TBL] [Abstract][Full Text] [Related]
5. MIB-1 and DNA topoisomerase II alpha could be helpful for predicting long-term survival of patients with glioblastoma. Ho DM; Hsu CY; Ting LT; Chiang H Am J Clin Pathol; 2003 May; 119(5):715-22. PubMed ID: 12760291 [TBL] [Abstract][Full Text] [Related]
6. Proliferation index as a predictor of prognosis in malignant gliomas of childhood. Pollack IF; Campbell JW; Hamilton RL; Martinez AJ; Bozik ME Cancer; 1997 Feb; 79(4):849-56. PubMed ID: 9024724 [TBL] [Abstract][Full Text] [Related]
7. Prognostic relevance of p53 protein expression in glioblastoma. Birner P; Piribauer M; Fischer I; Gatterbauer B; Marosi C; Ungersböck K; Rössler K; Budka H; Hainfellner JA Oncol Rep; 2002; 9(4):703-7. PubMed ID: 12066196 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas. Wakimoto H; Aoyagi M; Nakayama T; Nagashima G; Yamamoto S; Tamaki M; Hirakawa K Cancer; 1996 Jan; 77(2):373-80. PubMed ID: 8625247 [TBL] [Abstract][Full Text] [Related]
9. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas. Colman H; Giannini C; Huang L; Gonzalez J; Hess K; Bruner J; Fuller G; Langford L; Pelloski C; Aaron J; Burger P; Aldape K Am J Surg Pathol; 2006 May; 30(5):657-64. PubMed ID: 16699322 [TBL] [Abstract][Full Text] [Related]
10. A phase I/II trial of a WT1 (Wilms' tumor gene) peptide vaccine in patients with solid malignancy: safety assessment based on the phase I data. Morita S; Oka Y; Tsuboi A; Kawakami M; Maruno M; Izumoto S; Osaki T; Taguchi T; Ueda T; Myoui A; Nishida S; Shirakata T; Ohno S; Oji Y; Aozasa K; Hatazawa J; Udaka K; Yoshikawa H; Yoshimine T; Noguchi S; Kawase I; Nakatsuka S; Sugiyama H; Sakamoto J Jpn J Clin Oncol; 2006 Apr; 36(4):231-6. PubMed ID: 16611662 [TBL] [Abstract][Full Text] [Related]
11. Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer: from the Danish "MALOVA" ovarian cancer study. Høgdall EV; Christensen L; Kjaer SK; Blaakaer J; Christensen IJ; Gayther S; Jacobs IJ; Høgdall CK Gynecol Oncol; 2007 Aug; 106(2):318-24. PubMed ID: 17540436 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer. Vis AN; Noordzij MA; Fitoz K; Wildhagen MF; Schröder FH; van der Kwast TH J Urol; 2000 Dec; 164(6):2156-61. PubMed ID: 11061947 [TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort. Metellus P; Coulibaly B; Nanni I; Fina F; Eudes N; Giorgi R; Barrie M; Chinot O; Fuentes S; Dufour H; Ouafik L; Figarella-Branger D Cancer; 2009 Oct; 115(20):4783-94. PubMed ID: 19637364 [TBL] [Abstract][Full Text] [Related]
15. Ki-67 antigen expression as a prognostic factor in primary and recurrent astrocytomas. Eneström S; Vavruch L; Frånlund B; Nordenskjöld B Neurochirurgie; 1998 Mar; 44(1):25-30. PubMed ID: 9757314 [TBL] [Abstract][Full Text] [Related]
16. The role of MIB-1 index in the prognosis of resectable pancreatic head cancer. Shyr YM; Su CH; Li AF; Wu CW; Lui WY Hepatogastroenterology; 1999; 46(29):2968-73. PubMed ID: 10576384 [TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations. Shono T; Tofilon PJ; Bruner JM; Owolabi O; Lang FF Cancer Res; 2001 Jun; 61(11):4375-81. PubMed ID: 11389063 [TBL] [Abstract][Full Text] [Related]
18. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival. Zagzag D; Blanco C; Friedlander DR; Miller DC; Newcomb EW Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366 [TBL] [Abstract][Full Text] [Related]
19. High-grade astrocytomas show increased Nestin and Wilms's tumor gene (WT1) protein expression. Rushing EJ; Sandberg GD; Horkayne-Szakaly I Int J Surg Pathol; 2010 Aug; 18(4):255-9. PubMed ID: 19578047 [TBL] [Abstract][Full Text] [Related]
20. Analysis of immunohistochemical expression of p53 and the proliferation marker Ki-67 antigen in skull base chordomas: relationships between their expression and prognosis. Sakai K; Hongo K; Tanaka Y; Nakayama J Brain Tumor Pathol; 2007; 24(2):57-62. PubMed ID: 18095132 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]